C. Fava Gaspar
AuthID: R-00K-GJV
1
TÃTULO: Neoadjuvant durvalumab in non-surgical early stage/locally advanced non-small cell lung cancer (NSCLC) followed by radical RT/CRT (IDEAR) study concept of a phase II investigator initiated clinical trial
AUTORES: Gaspar, C. Fava; Oliveira, J.;
PUBLICAÇÃO: 2022, FONTE: Annual Meeting of the European-Society-for-Medical-Oncology (ESMO) in ANNALS OF ONCOLOGY, VOLUME: 33, NÚMERO: 7
AUTORES: Gaspar, C. Fava; Oliveira, J.;
PUBLICAÇÃO: 2022, FONTE: Annual Meeting of the European-Society-for-Medical-Oncology (ESMO) in ANNALS OF ONCOLOGY, VOLUME: 33, NÚMERO: 7
INDEXADO EM: 
WOS
WOS